Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
15,677
Total Claims
$3.4M
Drug Cost
542
Beneficiaries
$6,188
Cost/Patient
Risk Score Breakdown 10/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+479%
Cost per patient vs peers
$6,188 vs $1,068 avg
+213%
Brand preference vs peers
28.2% vs 9.0% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
Brand vs Generic
Brand: 4,327 claims · $2.9M
Generic: 11,021 claims · $446K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 901 | $421K |
| Semaglutide | 283 | $356K |
| Dapagliflozin Propanediol | 310 | $246K |
| Diclofenac Epolamine | 207 | $133K |
| Tenofovir Alafenamide | 85 | $129K |
| Empagliflozin | 165 | $129K |
| Semaglutide | 100 | $119K |
| Linaclotide | 164 | $110K |
| Sitagliptin Phosphate | 135 | $94K |
| Denosumab | 48 | $82K |
| Diclofenac Sodium | 262 | $81K |
| Sitagliptin Phos/Metformin Hcl | 122 | $81K |
| Mirabegron | 112 | $76K |
| Lactulose | 38 | $66K |
| Budesonide/Glycopyr/Formoterol | 70 | $59K |
Prescribing Profile
Patient Profile
75
Avg Age
54%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data